Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease.

Perretta-Tejedor N, Muñoz-Félix JM, Düwel A, Quiros-Luis Y, Fernández-Martín JL, Morales AI, López-Hernández FJ, López-Novoa JM, Martínez-Salgado C.

Acta Physiol (Oxf). 2019 Jun;226(2):e13247. doi: 10.1111/apha.13247. Epub 2019 Jan 18.

PMID:
30589223
2.

Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3.

Weinmüller M, Rechenmacher F, Kiran Marelli U, Reichart F, Kapp TG, Räder AFB, Di Leva FS, Marinelli L, Novellino E, Muñoz-Félix JM, Hodivala-Dilke K, Schumacher A, Fanous J, Gilon C, Hoffman A, Kessler H.

Angew Chem Int Ed Engl. 2017 Dec 18;56(51):16405-16409. doi: 10.1002/anie.201709709. Epub 2017 Nov 23.

PMID:
29072809
3.

Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition.

Olmos G, Muñoz-Félix JM, Mora I, Müller AG, Ruiz-Torres MP, López-Novoa JM, Rodríguez-Puyol D.

J Cell Mol Med. 2018 Jan;22(1):302-314. doi: 10.1111/jcmm.13319. Epub 2017 Aug 30.

4.

Dual role of pericyte α6β1-integrin in tumour blood vessels.

Reynolds LE, D'Amico G, Lechertier T, Papachristodoulou A, Muñoz-Félix JM, De Arcangelis A, Baker M, Serrels B, Hodivala-Dilke KM.

J Cell Sci. 2017 May 1;130(9):1583-1595. doi: 10.1242/jcs.197848. Epub 2017 Mar 13.

5.

Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction.

Muñoz-Félix JM, Pérez-Roque L, Núñez-Gómez E, Oujo B, Arévalo M, Ruiz-Remolina L, Cuesta C, Langa C, Pérez-Barriocanal F, Bernabeu C, Lopez-Novoa JM.

Biochim Biophys Acta. 2016 Sep;1862(9):1801-14. doi: 10.1016/j.bbadis.2016.06.010. Epub 2016 Jun 15.

6.

Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro.

Muñoz-Félix JM, Cuesta C, Perretta-Tejedor N, Subileau M, López-Hernández FJ, López-Novoa JM, Martínez-Salgado C.

Cell Signal. 2016 Sep;28(9):1252-61. doi: 10.1016/j.cellsig.2016.05.015. Epub 2016 May 18.

PMID:
27208502
7.

Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts.

Muñoz-Félix JM, Fuentes-Calvo I, Cuesta C, Eleno N, Crespo P, López-Novoa JM, Martínez-Salgado C.

J Cell Physiol. 2016 Oct;231(10):2224-35. doi: 10.1002/jcp.25340. Epub 2016 Mar 6.

PMID:
26873620
8.

TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

Muñoz-Félix JM, González-Núñez M, Martínez-Salgado C, López-Novoa JM.

Pharmacol Ther. 2015 Dec;156:44-58. doi: 10.1016/j.pharmthera.2015.10.003. Epub 2015 Oct 19. Review.

PMID:
26493350
9.

The role of endoglin in kidney fibrosis.

Muñoz-Felix JM, Oujo B, Lopez-Novoa JM.

Expert Rev Mol Med. 2014 Dec 2;16:e18. doi: 10.1017/erm.2014.20.

PMID:
25439793
10.

L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction.

Oujo B, Muñoz-Félix JM, Arévalo M, Núñez-Gómez E, Pérez-Roque L, Pericacho M, González-Núñez M, Langa C, Martínez-Salgado C, Perez-Barriocanal F, Bernabeu C, Lopez-Novoa JM.

PLoS One. 2014 Oct 14;9(10):e110365. doi: 10.1371/journal.pone.0110365. eCollection 2014.

11.

ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.

Muñoz-Félix JM, Perretta-Tejedor N, Eleno N, López-Novoa JM, Martínez-Salgado C.

Biochim Biophys Acta. 2014 Jun;1843(6):1111-22. doi: 10.1016/j.bbamcr.2014.02.017. Epub 2014 Mar 1.

12.

ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?

Muñoz-Félix JM, González-Núñez M, López-Novoa JM.

Cytokine Growth Factor Rev. 2013 Dec;24(6):523-37. doi: 10.1016/j.cytogfr.2013.08.002. Epub 2013 Sep 13. Review.

PMID:
24055043
13.

Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.

Muñoz-Félix JM, López-Novoa JM, Martínez-Salgado C.

Kidney Int. 2014 Feb;85(2):319-32. doi: 10.1038/ki.2013.292. Epub 2013 Aug 14.

14.

The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

González-Núñez M, Muñoz-Félix JM, López-Novoa JM.

Biochim Biophys Acta. 2013 Oct;1832(10):1492-510. doi: 10.1016/j.bbadis.2013.05.016. Epub 2013 May 22. Review.

15.

Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines.

Ferreira L, Fuentes-Calvo I, Muñoz-Félix JM, Muñiz-Martín C, Sánchez-Juanes F, Raposo C, González-Buitrago JM, López-Novoa JM, Martínez-Salgado C.

Electrophoresis. 2012 May;33(9-10):1385-96. doi: 10.1002/elps.201100606.

PMID:
22648805

Supplemental Content

Loading ...
Support Center